OS Insider Trade: CRO Nets $25.12 on 20k Share Sale
Rhea-AI Filing Summary
Form 4 discloses that Ken Hohenstein, Chief Revenue Officer of OneStream, Inc. (OS), executed and sold shares on 18 Jul 2025.
- Option exercise: 20,000 stock options were exercised at $10.65 (grant dated 5 Mar 2023; 25% vested 15 Feb 2024, remaining vest monthly).
- Open-market sale: The same 20,000 shares were sold at $25.12 under a Rule 10b5-1 plan adopted 13 Nov 2024.
Post-transaction holdings:
- Direct: 1,003,163 Class A shares (includes unvested RSUs).
- Indirect: 790,279 shares held by the Hohenstein Purple Elephant 2019 Irrevocable Grantor Trust.
- Options remaining: 238,508 shares.
The filing reflects no change in net share count from the option exercise/sale pair, but it shows the insider retains a substantial equity stake exceeding 1.79 million shares (direct + indirect) plus unexercised options.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine option exercise with matched sale; insider still holds >1 M shares—signal neutral.
The CRO converted 20 k options at $10.65 and immediately sold the shares at $25.12, locking in roughly $290 k gross proceeds. Because the same share count was exercised and disposed, there is no incremental buying or selling pressure on the float beyond this one-day volume. Remaining direct ownership of 1.0 M shares plus 238 k options indicates continued alignment with shareholders. The use of a pre-arranged 10b5-1 plan lowers concerns about opportunistic timing. Overall, the transaction appears ordinary course compensation management rather than a directional bet.
TL;DR: 10b5-1 structured sale limits governance risk; stake remains meaningful.
The filing confirms that the officer’s sale was executed under a Rule 10b5-1 plan established months prior, satisfying best-practice safeguards against insider trading allegations. Retention of over 1.8 M combined shares and an ongoing vesting schedule suggest long-term involvement. No red flags—such as sudden bulk liquidation or termination of Section 16 status—are present, so governance impact is minimal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 20,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 20,000 | $10.65 | $213K |
| Sale | Class A Common Stock | 20,000 | $25.12 | $502K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The shares reported include unvested restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024. Shares held by the Hohenstein Purple Elephant 2019 Irrevocable Grantor Trust (the "Hohenstein Purple Elephant Trust"). The Reporting Person may be deemed to have voting and dispositive power over the shares held by the Hohenstein Purple Elephant Trust. One-fourth of the shares subject to the option vested on February 15, 2024, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through the applicable vesting date.
